Lupin logo

Lupin share news, announcements and annual reports

NSE: LUPINBSE: 500257Pharmaceuticals & BiotechnologyMid Cap

Lupin Limited · Face value ₹2 · Listed Oct 1993 on BSE, Sep 2001 on NSE
Last close ₹2,011.00up ₹21.10 (1.06%)BSE ₹2,009.00

Share price at the NSE close on 30 Oct 2026. Previous close ₹1,989.90.

30 Oct: open ₹1,995.70, high ₹2,021.80, low ₹1,974.00

52-week range of traded prices to 30 Oct 2026
₹1,892.90Low, 23 Oct 2026₹2,529.50High, 16 Jul 2026
Market cap
₹91,961 Cr105th largest listed
P/E
16.63
P/E without one-offs
15.11
P/B
4.10
Dividend yield
0.90%
ROE
27.9%
ROE without one-offs
30.7%
ROCE
28.2%
Debt to equity
0.26
Volume, NSE
7,59,66358.6% delivered

Lupin share news and announcements

2,113 announcements, routine notices left out, newest first. Page 36 of 43.

  1. Jan 2012

    • 19 Jan · Disclosure

      Company has granted 6500 options to the employees of its subsidiary Companies, under "Lupin Subsidiary Companies Employees Stock Option Plan 2011" at the exercise price of Rs. 433.25 on January 18, 2012. Further the Company has informed that, one equity share of Rs. 2/- each is covered by each option. The options issued are exercisable at the 'market price' as defined in SEBI guidelines, in a phased manner after a minimum vesting period of 12 months but before the exercise period of 10 years from the date of grant.
    • 11 Jan · Board meeting

      Inter alia, to consider the unaudited financial results for the quarter ended December 31, 2011.
  2. Dec 2011

  3. Nov 2011

    • 28 Nov · Updates

      Barclays Wealth Trustees (India) Private Limited, the Trustee of the Lupin Employees Benefit Trust ("Trust") have informed us of purchase of shares of the Company in the open market aggregating to 4,53,900 shares at the average rate of Rs. 474.99 per share. The Trust is an independent trust set up for the welfare and benefit of the Company's employees. The aforementioned shares have been acquired in terms of the "Lupin Employees Stock Appreciation Rights Scheme" ("Scheme") which has been launched with a view to motivate employees to participate in the long term growth of the Company. As per the Scheme, the minimum holding period of the purchased shares shall be three years.
    • 22 Nov · Business

      Allotment Committee of Directors at its meeting held on November 22, 2011 has allotted 46524 fully paid up equity shares of Rs. 2/- each. These shares have been allotted upon exercising of options granted to the employees under Stock option plans of the Company. In view of the above, the issued and paid up capital of the Company has been increased to Rs. 89,31,73,054 consisting 44,65,86,527 equity shares of Rs. 2/- each.
    • 21 Nov · Disclosure

      Company has granted 50000 options to its employee, under "Lupin Employees Stock Option Plan 2005" at the exercise price of Rs. 223.25 on November 18, 2011. One equity share of Rs. 2/- each is covered by each option. The options issued are exercisable at the 'market price' as defined in SEBI guidelines, in a phased manner after a minimum vesting period of 12 months but before the exercise period of 10 years from the date of grant.
    • 9 Nov · Management

      Mr. K. V. Kamath, resigned from the directorship of the Company w.e.f. November 09, 2011.
    • 9 Nov · Results

      Lupin Limited had informed the Exchange regarding the standalone Results for the quarter ended on 30-SEP-2011 as follows: Net Sales of Rs. 109424 lacs for quarter ending on 30-SEP-2011 against Rs. 104869 lacs for the quarter ending on 30-SEP-2010. Net Profit / (Loss) of Rs. 7275 lacs for the quarter ending on 30-SEP-2011 against Rs. 16239 lacs for the quarter ending on 30-SEP-2010. Lupin Limited has now informed the Exchange regarding the revised standalone Results for the quarter ended on 30-SEP-2011 as follows: Net Sales of Rs. 138691 lacs for quarter ending on 30-SEP-2011 against Rs. 104869 lacs for the quarter ending on 30-SEP-2010. Net Profit / (Loss) of Rs. 26812 lacs for the quarter ending on 30-SEP-2011 against Rs. 16239 lacs for the quarter ending on 30-SEP-2010.
    • 9 Nov · Results

      Consolidated Results for the quarter ended on 30-SEP-2011 as follows: Net Sales of Rs. 174166 lacs for quarter ending on 30-SEP-2011 against Rs. 140505 lacs for the quarter ending on 30-SEP-2010. Net Profit / (Loss) of Rs. 26687 lacs for the quarter ending on 30-SEP-2011 against Rs. 21502 lacs for the quarter ending on 30-SEP-2010.
    • 9 Nov · Results

      Standalone Results for the quarter ended on 30-SEP-2011 as follows: Net Sales of Rs. 109424 lacs for quarter ending on 30-SEP-2011 against Rs. 104869 lacs for the quarter ending on 30-SEP-2010. Net Profit / (Loss) of Rs. 7275 lacs for the quarter ending on 30-SEP-2011 against Rs. 16239 lacs for the quarter ending on 30-SEP-2010.
  4. Oct 2011

  5. Sep 2011

  6. Aug 2011

    • 24 Aug · News Verification

      News Verification : The media had reports that Japanese Drugmaker Takeda is in talks to buy company's pharma business. The Exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Lupin Limited has vide its letter inter-alia stated,"In this regard, please note that the Company is not in discussions with Takeda for the purposes of selling its domestic formulations business as mentioned in the aforesaid article. As such, the news report referred above is entirely baseless and speculative in nature and does not merit any explanation from us."
    • 3 Aug · Disclosure

      Company has granted 1845750 options to its employees under "Lupin Employees Stock Option Plan 2011" at the exercise price of Rs. 455.65 on August 02, 2011. One equity share of Rs. 2/- each is covered by each option. The options issued are exercisable at the 'market price' as defined in SEBI guidelines, in a phased manner after a minimum vesting period of 12 months but before the exercise period of 10 years from the date of grant.
  7. Jul 2011

    • 29 Jul · Business

      Allotment Committee of Directors at its meeting held on July 29, 2011 has allotted 137032 fully paid up equity shares of Rs. 2/- each. These shares have been allotted upon exercising of options granted to the employees under Stock option plans of the Company. In view of the above, the issued and paid up capital of the Company has been increased to Rs. 89,28,69,262 consisting 44,64,34,631 equity shares of Rs. 2/- each.
    • 27 Jul · Results

      Consolidated Results for the quarter ended on 30-JUN-2011 as follows: Net Sales of Rs. 154318 lacs for quarter ending on 30-JUN-2011 against Rs. 131209 lacs for the quarter ending on 30-JUN-2010. Net Profit / (Loss) of Rs. 21008 lacs for the quarter ending on 30-JUN-2011 against Rs. 19630 lacs for the quarter ending on 30-JUN-2010.
    • 27 Jul · Results

      Standalone Results for the quarter ended on 30-JUN-2011 as follows: Net Sales of Rs. 109424 lacs for quarter ending on 30-JUN-2011 against Rs. 99707 lacs for the quarter ending on 30-JUN-2010. Net Profit / (Loss) of Rs. 7275 lacs for the quarter ending on 30-JUN-2011 against Rs. 15742 lacs for the quarter ending on 30-JUN-2010.
    • 22 Jul · Business

      The Company has granted 32500 options to its employee under 'Lupin Employees Stock Option Plan 2005', at the exercise price of Rs. 460.55 on July 21, 2011. Please note that one equity share of Rs. 2/- each is covered by each option. The option issued are exercisable at the 'market price' as defined in SEBI guidelines, in a phased manner after a minimum vesting period of 12 months but before the exercise period of 10 years from the date of grant
    • 14 Jul · Disclosure

      Company has granted 19,000 options to its employee of its subsidiary Company, under "Lupin Subsidiary Companies Employees Stock Option Plan 2011", at the exercise price of Rs. 458.30 on July 13, 2011. Further, one equity share of Rs. 2/- each is covered by each option. The options issued are exercisable at the 'market price' as defined in SEBI guidelines, in a phased manner after a minimum vesting period of 12 months but before the exercise period of 10 years from the date of grant.